In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

A research team led by Professor Jiwon Um from the Center for Synapse Diversity and Specificity at DGIST has discovered a ...

The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...

This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...

I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline. There are also new tests to determine if a person is in the beginning stages, ...

A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from ...

We often think of over-the-counter (OTC) medications as harmless because they don't require a doctor's signature. They sit in ...

Amplifying the brain's waste disposal system seems to clear a substance that drives migraines, relieving some of the pain ...

A breakthrough drug is fighting brain cancer head-on. Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly ...

A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.